Lilly cancer drug fails key trial, will no longer be prescribed

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 66%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Eli Lilly and Co said on Friday that its cancer treatment Lartruvo, which had won conditional approval, failed to improve patient survival in a ...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Lilly's cancer therapy Lartruvo fails to meet main goal in late-stage trialREUTERS: Eli Lilly and Co said on Friday its cancer treatment Lartruvo failed to meet the main goal in a late-stage trial testing the therapy in ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Exclusive: CVS to cover migraine drugs from Teva, Lilly; excludes AmgenCVS Health Corp, a top U.S. manager of pharmacy benefits, has added new migraine drugs from Teva Pharmaceutical Industries and Eli Lilly and Co to ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Lilly's cancer therapy Lartruvo fails to meet main goal in late-stage trialREUTERS: Eli Lilly and Co said on Friday its cancer treatment Lartruvo failed to meet the main goal in a late-stage trial testing the therapy in ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

AbbVie's cancer drug fails to meet main goal in late-stage studyREUTERS: AbbVie Inc said on Friday its cancer treatment in combination with chemotherapy agents failed to meet the main goal in a late-stage study ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Exclusive: CVS to cover migraine drugs from Teva, Lilly; excludes AmgenCVS Health Corp, a top U.S. manager of pharmacy benefits, has added new migraine drugs from Teva Pharmaceutical Industries and Eli Lilly and Co to ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »